ImportRefusal LogoImportRefusal

Programme de greffes de cellules hematoponetiques

⚠️ Moderate Risk

FEI: 1000269566 • Montreal, Quebec • CANADA

FEI

FEI Number

1000269566

📍

Location

Montreal, Quebec

🇨🇦

Country

CANADA
🏢

Address

5415 De l'Assomption Blvd, , Montreal, Quebec, Canada

Moderate Risk

FDA Import Risk Assessment

28.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
1
Unique Violations
10/18/2006
Latest Refusal
10/18/2006
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4761×

NO REGISTR

The article appears to be an electronic product that does not comply with an applicable standard as prescribed by Section 534 because no reporting has been provided as required by Section 537(b).

Refusal History

DateProductViolationsDivision
10/18/2006
94V07TV RECEIVER OR PRODUCT CONT. TV RECEIVER, TELEVISION, COMPUTER MONITOR
476NO REGISTR
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Programme de greffes de cellules hematoponetiques's FDA import refusal history?

Programme de greffes de cellules hematoponetiques (FEI: 1000269566) has 1 FDA import refusal record(s) in our database, spanning from 10/18/2006 to 10/18/2006.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Programme de greffes de cellules hematoponetiques's FEI number is 1000269566.

What types of violations has Programme de greffes de cellules hematoponetiques received?

Programme de greffes de cellules hematoponetiques has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Programme de greffes de cellules hematoponetiques come from?

All FDA import refusal data for Programme de greffes de cellules hematoponetiques is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.